Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had revenue of $18.88M in the quarter ending September 30, 2024, with 33.36% growth. This brings the company's revenue in the last twelve months to $71.17M, up 73.45% year-over-year. In the fiscal year ending March 31, 2024, Elite Pharmaceuticals had annual revenue of $56.63M with 65.79% growth.

• Revenue (ttm): 71.17M
• Revenue Growth: +73.45%
• P/S Ratio: 7.40
• Revenue / Employee: 1.11M
• Employees: 64
• Market Cap: 539.48M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	56.63M	22.47M	65.79%
Mar 31, 2023	34.16M	1.89M	5.87%
Mar 31, 2022	32.26M	6.88M	27.11%
Mar 31, 2021	25.38M	7.39M	41.05%
Mar 31, 2020	17.99M	10.43M	137.76%